Reckitt Benckiser Group PLC — Director's Dealing 2017

Mar 20, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9803Z

Reckitt Benckiser Group PLC

20 March 2017

20 March 2017

RECKITT BENCKISER GROUP PLC

("RB" or the "Company")

DIRECTOR/PDMR SHAREHOLDING

Notification of transactions of Directors/Persons Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

On 20 March 2017, Rob de Groot, Area Executive Vice President ENA, a PDMR, transferred 255,505 Shares to his spouse, Danielle Van Dommelen, by way of a non-market transfer for nil consideration. There was no change in the ultimate beneficial ownership of the Shares as a result of the transfer.

Following the transaction, Mr de Groot's shareholding (including beneficial interest) is 313,675 Shares, representing 0.0448% of the Company's issued share capital. Treasury shares have not been taken into account when calculating this percentage.

The following notification is made in accordance with the requirements of the EU Market Abuse Regulation.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Rob de Groot

2

Reason for the notification

a)

Position/status

Area EVP, ENA

b)

Initial notification/

Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Reckitt Benckiser Group plc

b)

LEI

5493003JFSMOJG48V108

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10p each in Reckitt Benckiser Group plc ("Shares")

GB00B24CGK77

b)

Nature of the transaction

Non-market transfer of 255,505 Shares from Rob de Groot to Danielle Van Dommelen for nil consideration. No change in beneficial ownership.

c)

Price(s) and volume(s)

Price(s)	Volume(s)
nil	255,505

d)

Aggregated information

-       Aggregated volume

-       Price

-

-

e)

Date of the transaction

2017-03-20

f)

Place of the transaction

Outside a trading venue

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Danielle Van Dommelen

2

Reason for the notification

a)

Position/status

PCA to Rob de Groot

b)

Initial notification/

Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Reckitt Benckiser Group plc

b)

LEI

5493003JFSMOJG48V108

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10p each in Reckitt Benckiser Group plc ("Shares")

GB00B24CGK77

b)

Nature of the transaction

Non-market transfer of 255,505 Shares from Rob de Groot to Danielle Van Dommelen for nil consideration. No change in beneficial ownership.

c)

Price(s) and volume(s)

Price(s)	Volume(s)
nil	255,505

d)

Aggregated information

-       Aggregated volume

-       Price

-

-

e)

Date of the transaction

2017-03-20

f)

Place of the transaction

Outside a trading venue

For further Information:

Christine Logan

Deputy Company Secretary

Tel +44 (0) 1753 217 800

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

About RB:

RB* is the world's leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in London, Dubai and Amsterdam, and sales in most countries across the globe. The company employs approximately 37,000 people worldwide.

Inspired by a purpose to deliver innovative solutions for healthier lives and happier homes, RB is in the top 20 companies listed on the London Stock Exchange. We are the global No 1 or No 2 in the majority of our fast-growing categories, driven by an exceptional focus on innovation. Our health, hygiene and home portfolio is led by our global Powerbrands including Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Air Wick, Woolite and French's. Our Powerbrands represent 80% of net revenue.

RB is redefining the world of consumer health and hygiene. Our people and unique culture are at the heart of our success. We have a drive for achievement and a passion to outperform wherever we focus, including sustainability where we are targeting a 1/3 reduction in water impact, 1/3 reduction in carbon and 1/3 of net revenue from more sustainable products. We are proud to be Save the Children's largest global partner, with a new vision to radically reduce one of the world's largest killers of under 5s, diarrhoea. 

For more information visit www.rb.com 

*RB is the trading name of the Reckitt Benckiser group of companies

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBSGDXDUDBGRG